“AI as Reinvention”: Transforming the Business of Medicine

In this episode of the Pharm Exec podcast, Emmanuel Frenehard, executive vice president and chief digital officer at Sanofi, shares how one of the world's largest pharma companies is moving artificial intelligence from proof-of-concept to enterprise scale by embedding AI throughout R&D, manufacturing, commercial operations, and the employee experience. Joining Mike Christel, group managing editor, MJH Life Sciences, Frenehard breaks down Sanofi's three-tiered AI strategy — snackable, specialized, and generative — and explains why the organization views AI as a catalyst for reinvention rather than simply automation.

Frenehard also discusses the governance and cultural changes required to scale responsibly, and outlines how Sanofi's growing AI centers of excellence are helping shape the next generation of pharmaceutical innovation.